Singapore markets close in 2 hours
Straits Times Index
3,238.91 +13.46 (+0.42%) Nikkei
27,574.43 -111.97 (-0.40%) Hang Seng
19,426.94 +612.12 (+3.25%) FTSE 100
7,489.19 -32.20 (-0.43%) BTC-USD
16,816.18 -141.56 (-0.83%) CMC Crypto 200
394.59 -7.44 (-1.85%)
Orphazyme A/S (1TB.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 08:01AM CET. Market open.
| Previous close | 0.1220 |
| Open | 0.1255 |
| Bid | 0.1356 x 70000 |
| Ask | 0.1564 x 70000 |
| Day's range | 0.1255 - 0.1255 |
| 52-week range | 0.1220 - 2.7640 |
| Volume | |
| Avg. volume | 187 |
| Market cap | 5.407M |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.4110 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
- Zacks
Orphazyme (ORPH) Up on Plans of NDA Resubmission for Rare Drug
Orphazyme (ORPH) is looking to resubmit its NDA for arimoclomol to the FDA for the treatment of Niemann-Pick disease type C in the United States. Shares rise.
© 2022 Yahoo. All rights reserved.
